Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New diabetes pill takes on semaglutide in Head-to-Head trial

NCT ID NCT06045221

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Sep 16, 2026 · Updated 2 times

Summary

This phase 3 study tested a new once-daily pill called orforglipron against an existing oral semaglutide in nearly 1,700 adults with type 2 diabetes whose blood sugar was not well controlled on metformin. The main goal was to see how well orforglipron lowers blood sugar levels over about 61 weeks. Researchers also looked at weight loss and safety.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
orforglipron (LY3502970)
What this could lead to
If it works, this could offer a new once-daily pill option for type 2 diabetes that may lower blood sugar and help with weight loss.
What could go wrong
This is a completed phase 3 trial, but results are not yet published. Orforglipron may not prove better than semaglutide, and side effects like nausea or vomiting are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 3

Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.

Participants

1,698 people

The number who actually took part.

Started

Sep 2023

Finished

Aug 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Have Type 2 Diabetes * Have HbA1c ≥7.0% (53 mmol/mol) to ≤10.5% (91 mmol/mol), as determined by the central laboratory at screening. * Have been on stable diabetes treatment with metformin ≥1500 milligram (mg)/day during the 90 days prior to screening and maintained through randomization. * Are of stable body weight (±5%) for at least 90 days prior to screening and agree to not initiate an intensive diet or exercise program during the study with the intent of reducing body weight, other than the lifestyle and/or dietary measures for diabetes treatment Exclusion Criteria: * Have Type 1 Diabetes * Are currently receiving or planning to receive treatment for diabetic retinopathy and/or macular edema, for example, laser photocoagulation or intravitreal injections of anti-vascular endothelial growth factor inhibitors. * Have a history of ketoacidosis or hyperosmolar state or coma within the last 6 months prior to screening, or between screening and randomization. * Have a New York Heart Association functional classification IV congestive heart failure. * Have an estimated glomerular filtration rate (eGFR) \<45 milliliter/minute (mL/min)/1.73 square meter (m²) or lower than the country-specific threshold for discontinuing metformin therapy per local label as determined by the central laboratory at screening. * Have a serum calcitonin level of ≥35 nanogram/Liter (ng/L), as determined by the central laboratory at screening. * Have a history of an active or untreated malignancy or are in remission from a clinically significant malignancy for less than 5 years.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Type 2 diabetes are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Absolute Clinical Research

    Phoenix, Arizona, 85051, United States

  • Accellacare - Piedmont

    Statesville, North Carolina, 28625, United States

  • Affiliated Hospital of Jiangsu University

    Zhenjiang, Jiangsu, 212000, China

  • Albany Medical College, Division of Community Endocrinology

    Albany, New York, 12203, United States

  • Alliance for Multispecialty Research, LLC

    Norman, Oklahoma, 73069, United States

  • American Health Network of Indiana, LLC - Greenfield

    Greenfield, Indiana, 46140, United States

  • Aventiv Research Inc

    Columbus, Ohio, 43213, United States

  • Balanced Life Health Care Solutions/SKYCRNG

    Lawrenceville, Georgia, 30046, United States

  • Beijing Pinggu District Hospital

    Beijing, Beijing Municipality, 101200, China

  • Biopharma Informatic, LLC

    Los Angeles, California, 90035, United States

  • CICEJ Centro de Investigación Clínica Endocrinológica de Jalisco S.C

    Guadalajara, Jalisco, 44670, Mexico

  • CIMeL

    Lanus, Buenos Aires, B1824KAJ, Argentina

  • CIPREC

    Buenos Aires, Buenos Aires F.D., C1061AAS, Argentina

  • Caimed Investigacion En Salud S.A. de C.V.

    Mexico City, Mexico City, 06760, Mexico

  • Cardiolink Clin Trials

    Monterrey, Nuevo León, 64060, Mexico

  • Centro Especializado En Diabetes, Obesidad Y Prevencion De Enfermedades Cardiovasculares

    Mexico City, Mexico City, 11650, Mexico

  • Centro Médico Viamonte

    Buenos Aires, Buenos Aires F.D., C1120AAC, Argentina

  • Centro Para El Desarrollo de La Medicina Y de Asistencia Medica Especializada S.C.

    Culiacán, Sinaloa, 80230, Mexico

  • Centro de Investigacion Medica Integral

    Guadalajara, Jalisco, 44160, Mexico

  • Centro de Investigacion Medica de Occidente, S.C.

    Zapopan, Jalisco, 44260, Mexico

  • Centro de Investigaciones Metabólicas (CINME)

    Ciudad Autónoma de Buenos Aires, Buenos Aires, 1056, Argentina

  • Centro de Investigaciones Médicas Mar del Plata

    Mar del Plata, Buenos Aires, 7600, Argentina

  • Centro de Salud e Investigaciones Médicas

    Santa Rosa, La Pampa Province, 6300, Argentina

  • Centro de investigación y control metabólico

    San Nicolás de los Garza, Nuevo León, 66465, Mexico

  • Chongqing General Hospital

    Chongqing, Chongqing Municipality, 400014, China

  • Clear Brook Medical Associates

    Houston, Texas, 77089, United States

  • Clinical Neuroscience Solutions Inc.

    Memphis, Tennessee, 38119, United States

  • Clinical Research Atlanta

    Stockbridge, Georgia, 30281, United States

  • Clinical Research of West Florida

    Tampa, Florida, 33606, United States

  • Clinical Research of West Florida, Inc. (Clearwater)

    Clearwater, Florida, 33765, United States

  • Clínica García Flores SC

    Monterrey, Nuevo León, 64610, Mexico

  • Connecticut Clinical Research - Cromwell

    Cromwell, Connecticut, 06416, United States

  • Consultorio de Investigación Clínica EMO SRL

    Buenos Aires, Buenos Aires F.D., 1405, Argentina

  • Cotton O'Neil Diabetes & Endocrinology

    Topeka, Kansas, 66606, United States

  • Dalian Municipal Central Hospital Affiliated of Dalian Medical University

    Dalian, Liaoning, 116033, China

  • DelRicht Research

    New Orleans, Louisiana, 70115, United States

  • Diabetes and Thyroid Center of Ft. Worth

    Fort Worth, Texas, 76132, United States

  • Eastside Research Associates

    Redmond, Washington, 98052, United States

  • Ellipsis Research Group - Brooklyn - 7th Street

    Brooklyn, New York, 11215, United States

  • Encompass Clinical Research

    Spring Valley, California, 91978, United States

  • Endocrine Ips, Pllc

    Houston, Texas, 77079, United States

  • Eukarya PharmaSite

    Monterrey, Nuevo León, 64718, Mexico

  • Family First Medical Center

    Idaho Falls, Idaho, 83404, United States

  • First Affiliated Hospital of Kunming Medical University

    Kunming, Yunnan, 650032, China

  • Fundacion Estudios Clinicos

    Rosario, Santa Fe Province, S2000DEJ, Argentina

  • Gifu University Hospital

    Gifu, 501-1112, Japan

  • Great Lakes Medical Research, LLC

    Westfield, New York, 14787, United States

  • Heritage Valley Medical Group, Inc.

    Beaver, Pennsylvania, 15009, United States

  • Hospital Universitario "Dr. Jose Eleuterio Gonzalez"

    Monterrey, Nuevo León, 66460, Mexico

  • Huizhou Municipal Central Hospital

    Huizhou, Guangdong, 516001, China

  • Huzhou Central Hospital

    Huzhou, Zhejiang, 313000, China

  • INECO Neurociencias Oroño

    Rosario, Santa Fe Province, 2000, Argentina

  • Infinity Clinical Research - Norco

    Norco, California, 92860, United States

  • Instituto Centenario

    CABA, Buenos Aires F.D., 1204, Argentina

  • Instituto Jalisciense de Investigacion en Diabetes y Obesidad

    Guadalajara, Jalisco, 44600, Mexico

  • Instituto Médico Catamarca IMEC

    Rosario, Santa Fe Province, 2000, Argentina

  • Instituto Médico DAMIC

    Córdoba, 5003DCE, Argentina

  • Instituto Médico Fundación Grupo Colaborativo Rosario Investigación y Prevención Medica

    Rosario, Santa Fe Province, 2000, Argentina

  • Instituto de Especialidades de la Salud Rosario

    Rosario, Santa Fe Province, 2000, Argentina

  • Instituto de Investigaciones Clínicas Córdoba

    Córdoba, 5000, Argentina

  • Isis Clinical Research Center

    Guaynabo, PR, 00968, Puerto Rico

  • Jiangxi Pingxiang People's Hospital

    Pingxiang, Jiangxi, 337055, China

  • Jinan Central Hospital

    Jinan, Shandong, 250013, China

  • Joslin Diabetes Center

    Boston, Massachusetts, 02215, United States

  • Juno Research

    Houston, Texas, 77040, United States

  • Kansas City Research Institute

    Kansas City, Missouri, 64131, United States

  • Lahoja. Asociacion Para La Investigacion Y La Farmacovigilancia

    Durango, 34000, Mexico

  • Latin Clinical Trial Center

    San Juan, 00909, Puerto Rico

  • Latin Clinical Trial Center Florida

    Tamarac, Florida, 33321, United States

  • Logan Health Research

    Kalispell, Montana, 59901, United States

  • Lucas Research, Inc

    Morehead City, North Carolina, 28557, United States

  • Manda Memorial Hospital

    Sapporo, Hokkaido, 060-0062, Japan

  • Medical Corporation Sato Medical clinic

    Ootaku, Tokyo, 143-0015, Japan

  • Metabolic Research Institute, Inc.

    West Palm Beach, Florida, 33401, United States

  • Mgcendo Llc

    San Juan, PR, 00921, Puerto Rico

  • Miami Dade Medical Research Institute, LLC

    Miami, Florida, 33176, United States

  • Mikannohana Clinic, Diabetes, Endocrinology and Metabolism

    Matsuyama, Ehime, 116099, Japan

  • Nakakinen clinic

    Naka, Ibaraki, 311-0113, Japan

  • Nakamoto Internal Medicine Clinic

    Mito, Ibaraki, 310-0826, Japan

  • Nanjing First Hospital

    Nanjing, Jiangsu, 210006, China

  • Nanyang First People's Hospital

    Nanyang, Henan, 473014, China

  • Neighborhood Healthcare Institute of Health

    Escondido, California, 92025, United States

  • New Phase Research and Development

    Knoxville, Tennessee, 37909, United States

  • New West Physicians Clinical Research

    Golden, Colorado, 80401, United States

  • Norcal Endocrinology & Internal Medicine

    San Ramon, California, 94583, United States

  • North Georgia Clinical Research

    Woodstock, Georgia, 30189, United States

  • Northwest Clinical Trials

    Boise, Idaho, 83704, United States

  • Ohishi Internal Medicine Clinic

    Tsuchiura, Ibaraki, 300-0835, Japan

  • PharmQuest Life Sciences, LLC

    Greensboro, North Carolina, 27408, United States

  • Policlinica Red OMIP

    Mar del Plata, Buenos Aires, 7600, Argentina

  • Preferred Primary Care Physicians, Preferred Clinical Research (Ofc 18)

    Pittsburgh, Pennsylvania, 15236, United States

  • Premier Research

    Trenton, New Jersey, 08611, United States

  • Private Practice - Dr. Arechavaleta Granell Maria del Rosario

    Guadalajara, Jalisco, 44670, Mexico

  • Pudong New Area People's Hospital Shanghai

    Shanghai, Shanghai Municipality, 201200, China

  • Rainier Clinical Research Center

    Renton, Washington, 98057, United States

  • Research and Cardiovascular Corp.

    Ponce, 00717, Puerto Rico

  • Revival Research Institute, LLC

    Dearborn, Michigan, 48126, United States

  • SKY Integrative Medical Center/SKYCRNG

    Ridgeland, Mississippi, 39157, United States

  • San Fernando Valley Health Institute

    Canoga Park, California, 91304, United States

  • Sanatorio Norte

    Santiago del Estero, 4200, Argentina

  • Shanghai Sixth People's Hospital

    Shanghai, Shanghai Municipality, 200030, China

  • Shiraiwa Medical Clinic

    Kashihara, Osaka, 582-0005, Japan

  • Shunde Hospital of Southern Medical Univesity

    Foshan, Guangdong, 528399, China

  • South Florida Clinical Research Institute

    Margate, Florida, 33063, United States

  • Southern Endocrinology Associates

    Mesquite, Texas, 75149, United States

  • Synexus Clinical Research US, Inc.

    Salt Lake City, Utah, 84106, United States

  • Takai Internal Medicine Clinic

    Kamakura-shi, Kanagawa, 247-0056, Japan

  • Tekton Research, Inc

    Wichita, Kansas, 67218, United States

  • Tekton Research, Inc

    Moore, Oklahoma, 73160, United States

  • Texas Valley Clinical Research

    Weslaco, Texas, 78596, United States

  • The Corvallis Clinic, P.C.

    Corvallis, Oregon, 97330, United States

  • The First Affiliated Hospital of Henan University of Science &Technology

    Luoyang Shi, Henan, 471003, China

  • The First Affiliated Hospital of Wenzhou Medical University

    Wenzhou, Zhejiang, 325000, China

  • The Fourth Hospital of Harbin Medical University

    Harbin, Heilongjiang, 150001, China

  • The Research Center of The Upstate

    Greenville, South Carolina, 29607, United States

  • The Second Affiliated Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210011, China

  • The Second Affiliated Hospital of Zhengzhou University

    Zhengzhou, Henan, 450014, China

  • Unidad biomedica avanzada monterrey

    Monterrey, Nuevo León, 64460, Mexico

  • University Clinical Investigators, Inc.

    Tustin, California, 92780, United States

  • Valley Clinical Trials, Inc.

    Northridge, California, 91325, United States

  • Velocity Clinical Research, Austin

    Austin, Texas, 78759, United States

  • Velocity Clinical Research, Dallas

    Dallas, Texas, 75230, United States

  • Velocity Clinical Research, Gardena

    Gardena, California, 90247, United States

  • Velocity Clinical Research, Valparaiso

    Valparaiso, Indiana, 46383, United States

  • Velocity Clinical Research, Westlake

    Los Angeles, California, 90057, United States

  • Virgen Cardiovascular Research SC

    Guadalajara, Jalisco, 44670, Mexico

  • Wake Forest University Baptist Medical Center (WFUBMC)

    Winston-Salem, North Carolina, 27104, United States

  • West China Hospital of Sichuan University

    Chengdu, Sichuan, 610041, China

  • West Orange Endocrinology

    Ocoee, Florida, 34761, United States

  • Wr-Crcn, Llc

    Las Vegas, Nevada, 89106, United States

  • Zhejiang Hospital

    Hangzhou, Zhejiang, 310013, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.